Table of Contents
1 Industry Outlook 10
1.1 Industry Overview 10
1.2 Patient demographics 12
1.3 Healthcare Spending in the US 14
1.4 Definition: Brachytherapy 15
1.5 Why brachytherapy? 15
1.6 Industry Trends 15
1.7 Emerging Global Markets 16
2 Report Outline 18
2.1 Report Scope 18
2.2 Report Summary 18
2.3 Research Methodology 19
2.4 Report Assumptions 20
3 Market Snapshot 21
3.1 Total Addressable Market (TAM) 21
3.2 Funding Scenario 22
3.3 Segmented Addressable Market (SAM) 22
3.4 Porter 5 (Five) Forces 25
3.5 Market Dynamics 26
3.5.1 Drivers 27
3.5.1.1 Rise in the incidence of cancer globally 27
3.5.1.2 Increasing popularity of MI surgeries 27
3.5.1.3 Increase in the number of outpatient procedures 27
3.5.1.4 Rise in elderly population 28
3.5.2 Restraints 28
3.5.2.1 Complications and risks associated with brachytherapy procedures 28
3.5.2.2 High costs of instrument and therapy 28
3.5.2.3 Lack of trained technicians in developing countries 29
3.5.2.1 Intense competition among vendors 29
3.5.3 Opportunities 29
3.5.3.1 Advancement in technology 29
3.5.3.2 Increasing adoption of non-invasive procedures in emerging countries 30
3.5.3.1 Increasing healthcare spending 30
3.5.3.1 Shift toward minimal and non-invasive procedures 31
3.5.4 DRO - Impact Analysis 32
3.5.5 Key Stakeholders 33
4 Brachytherapy Market Segmentation by Methods: Market Size & Analysis 34
4.1 Overview 34
4.2 High-dose Rate Brachytherapy Market 37
4.2.1 Overview 37
4.3 Low-dose Rate Brachytherapy Market 37
4.3.1 Overview 37
4.4 Intermediate Dose Rate Brachytherapy Market 38
4.4.1 Overview 38
4.5 Pulsed Dose Rate Brachytherapy Market 39
4.5.1 Overview 39
5 Brachytherapy Market Segmentation By consumables 40
5.1 Overview 40
5.2 Seeds 40
5.3 Applicators' Afterloaders' and Other Accessories 41
6 Brachytherapy Market Segmentation by Applications 43
6.1 Overview 43
6.2 Prostate Cancer 43
6.3 Cervical Cancer 44
6.4 Breast Cancer 44
6.5 Lung Cancer 45
6.6 Head & Neck Cancer 46
6.7 Brain Cancer 47
6.8 Others 47
7 End-users: Market Size and Analysis 48
7.1 Overview 48
7.2 Hospitals 48
7.3 Radiation Therapy Centers 49
7.4 Ambulatory Surgery Centers 49
7.5 Others 49
8 Regions: Market Size & Analysis 51
8.1 Overview 51
8.2 North America 52
8.2.1 Market Overview 52
8.2.2 US 53
8.2.3 Canada 54
8.3 Europe 54
8.3.1 Market Overview 54
8.3.2 UK 55
8.3.3 Germany 55
8.3.4 France 56
8.3.5 Spain 56
8.4 APAC 56
8.4.1 Market Overview 56
8.4.2 India 57
8.4.3 China 58
8.4.4 Japan 59
8.5 Rest of the World 59
8.5.1 Market Overview 59
8.5.2 Brazil 60
8.5.3 Middle East 60
9 Competitive Landscape 62
9.1 Competitor Comparison Analysis 62
10 Vendor Profiles 64
10.1 Elekta AB 64
10.1.1 Overview 64
10.1.2 Geographic Revenue 68
10.1.3 Business Focus 68
10.1.4 SWOT Analysis 69
10.1.5 Business Strategies 69
10.2 Varian Medical Systems Inc. 70
10.2.1 Overview 70
10.2.2 Business Units 74
10.2.3 Geographic Revenue 75
10.2.4 Business Focus 75
10.2.5 SWOT Analysis 76
10.2.6 Business Strategies 76
10.3 C. R. Bard Inc. 78
10.3.1 Overview 78
10.3.2 Business Units 80
10.3.3 Business Focus 81
10.3.4 SWOT Analysis 81
10.3.5 Business Strategies 81
10.4 Eckert & Ziegler BEBIG 83
10.4.1.1 Overview 83
10.4.1.2 Business Units 85
10.4.1.3 Business Units 85
10.4.1.4 Geography 86
10.4.1.5 Business Focus 86
10.4.1.6 SWOT Analysis 87
10.4.1.7 Business Strategies 87
10.5 Theragenics Corp 88
10.5.1.1 Overview 88
10.5.1.2 Business Units 89
10.5.1.3 Business Focus 89
10.5.1.4 SWOT Analysis 89
10.5.1.5 Business Strategies 90
11 Companies to watch for 90
11.1 Carl Zeiss Meditec AG 91
11.1.1 Overview 91
11.2 Mevion Medical Systems Inc. 92
11.2.1 Overview 92
11.3 Nordion Inc. 93
11.3.1 Overview 93
11.4 IsoRay Inc. 95
11.4.1 Overview 95
11.5 Hitachi Medical Corp. 96
11.5.1 Overview 96
11.6 ViewRay Inc. 98
11.6.1 Overview 98

?